Full Press Release Details
[et_pb_section fb_built=”1″ _builder_version=”4.16″ custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_post_title author=”off” categories=”off” comments=”off” admin_label=”Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – %22Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more%22″ _builder_version=”4.23.4″ title_level=”h2″ title_text_color=”#0c71c3″ title_font_size=”28px” title_letter_spacing=”1px” title_line_height=”1.4em” meta_text_color=”#000000″ hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_post_title][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_button button_url=”https://www.biotechtv.com/post/sutro-biopharma-april-4-2024″ url_new_window=”on” button_text=”View Interview” button_alignment=”left” admin_label=”View Interview – Button” _builder_version=”4.23.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”A||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_button][et_pb_text _builder_version=”4.23.4″ _module_preset=”default” text_text_color=”#000000″ text_font_size=”19px” text_letter_spacing=”1px” text_line_height=”1.8em” hover_enabled=”0″ sticky_enabled=”0″]
Bill Newell describes this week’s deal with Ipsen, the folate receptor alpha space, designing therapies with non-cell protein synthesis, and Sutro’s numerous partnerships
Speakers:
• Bill Newell, CEO, Sutro Biopharma
• Bard Loncar, Founder, Biotech TV
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]